Page last updated: 2024-10-25

ciprofloxacin and Bancroftian Elephantiasis

ciprofloxacin has been researched along with Bancroftian Elephantiasis in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aglomasa, BC1
Adu-Asiamah, CK1
Asiedu, SO1
Kini, P1
Amewu, EKA1
Boahen, KG1
Wireko, S1
Amponsah, IK1
Boakye, YD1
Boamah, VE1
Kwarteng, A1

Other Studies

1 other study available for ciprofloxacin and Bancroftian Elephantiasis

ArticleYear
Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana.
    BMC microbiology, 2022, 10-11, Volume: 22, Issue:1

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Chlorampheni

2022